EP 3638694 A1 20200422 - COMPOSITIONS AND METHODS FOR TREATING TAUOPATHIES
Title (en)
COMPOSITIONS AND METHODS FOR TREATING TAUOPATHIES
Title (de)
ZUSAMMENSETZUNGEN UND VERFAHREN ZUR BEHANDLUNG VON TAUOPATHIEN
Title (fr)
COMPOSITIONS ET MÉTHODES DE TRAITEMENT DE TAUOPATHIES
Publication
Application
Priority
US 2017037991 W 20170616
Abstract (en)
[origin: WO2018231254A1] Dosage regimens and formulations of anti-human tau antibodies are provided. These formulations and dosage regimens find use in the treatment of tauopathies such as progressive supranuclear palsy and Alzheimer's disease.
IPC 8 full level
C07K 16/18 (2006.01); A61K 39/395 (2006.01); A61P 25/28 (2006.01)
CPC (source: EA EP KR)
A61K 47/18 (2013.01 - KR); A61K 47/22 (2013.01 - KR); A61K 47/26 (2013.01 - KR); A61P 25/28 (2017.12 - EA EP KR); C07K 16/18 (2013.01 - EA EP KR); A61K 2039/505 (2013.01 - EA EP KR); A61K 2039/545 (2013.01 - EA EP KR); C07K 2317/24 (2013.01 - EA EP KR)
Citation (search report)
See references of WO 2018231254A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2018231254 A1 20181220; AU 2017418317 A1 20191205; BR 112019026298 A2 20200714; CA 3064550 A1 20181220; CN 110770253 A 20200207; EA 202090063 A1 20200403; EP 3638694 A1 20200422; IL 271256 A 20200130; JP 2020529394 A 20201008; JP 2022033757 A 20220302; KR 20200018502 A 20200219; MX 2019015071 A 20200213
DOCDB simple family (application)
US 2017037991 W 20170616; AU 2017418317 A 20170616; BR 112019026298 A 20170616; CA 3064550 A 20170616; CN 201780091913 A 20170616; EA 202090063 A 20170616; EP 17743107 A 20170616; IL 27125619 A 20191208; JP 2019569225 A 20170616; JP 2021182954 A 20211110; KR 20197038545 A 20170616; MX 2019015071 A 20170616